Non-radiographic Axial Spondyloarthritis

The fifth update from the American College of Rheumatology supports fourth doses of the vaccine for high-risk rheumatic disease patients.

Promising results were announced by UCB after a Phase 3 study evaluated bimekizumab for non-radiographic axial spondyloarthritis and met all endpoints.

The 2 studies focused on upadacitinib treatment for one group of patients with ankylosing spondylitis and another group of patients with non-radiographic axial spondyloarthritis.

High levels of sedentary activity and low levels of physical activity found in patients with axSpA

With nr-ax-SpA newly identified as an ICD-10 code, Jeff Stark, MD, discusses why this is so important for patients and clinicians alike.